Suppr超能文献

相似文献

3
Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function.
J Clin Invest. 2015 Mar 2;125(3):1299-310. doi: 10.1172/JCI76453. Epub 2015 Feb 17.
5
Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.
Antioxid Redox Signal. 2016 Sep 1;25(7):435-50. doi: 10.1089/ars.2015.6556. Epub 2016 Apr 5.
6
Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.
Circ J. 2011;75(12):2722-30. doi: 10.1253/circj.cj-11-1124. Epub 2011 Nov 10.
7
A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis.
Circulation. 2013 Jan 29;127(4):486-99. doi: 10.1161/CIRCULATIONAHA.112.116988. Epub 2012 Dec 14.
10
PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation.
J Cell Biol. 2011 May 30;193(5):867-84. doi: 10.1083/jcb.201010051.

引用本文的文献

3
Exploring potential targets for natural product therapy of DN: the role of SUMOylation.
Front Pharmacol. 2024 Oct 4;15:1432724. doi: 10.3389/fphar.2024.1432724. eCollection 2024.
4
The Perspectives of Platelet Proteomics in Health and Disease.
Biomedicines. 2024 Mar 6;12(3):585. doi: 10.3390/biomedicines12030585.
6
Metabolic regulation of endothelial senescence.
Front Cardiovasc Med. 2023 Aug 15;10:1232681. doi: 10.3389/fcvm.2023.1232681. eCollection 2023.
7
Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors.
Front Cardiovasc Med. 2023 Jun 2;10:1186679. doi: 10.3389/fcvm.2023.1186679. eCollection 2023.
8
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis.
Circ Res. 2023 Jun 23;133(1):25-44. doi: 10.1161/CIRCRESAHA.122.322017. Epub 2023 Jun 2.
9
Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Pharmacol Rev. 2023 Sep;75(5):979-1006. doi: 10.1124/pharmrev.122.000784. Epub 2023 May 3.
10
The role of SUMOylation in the neurovascular dysfunction after acquired brain injury.
Front Pharmacol. 2023 Mar 22;14:1125662. doi: 10.3389/fphar.2023.1125662. eCollection 2023.

本文引用的文献

1
A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis.
Circulation. 2013 Jan 29;127(4):486-99. doi: 10.1161/CIRCULATIONAHA.112.116988. Epub 2012 Dec 14.
3
Immune modulation of vascular resident cells by Axl orchestrates carotid intima-media thickening.
Am J Pathol. 2012 May;180(5):2134-43. doi: 10.1016/j.ajpath.2012.01.036.
4
Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.
Circ J. 2011;75(12):2722-30. doi: 10.1253/circj.cj-11-1124. Epub 2011 Nov 10.
6
PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation.
J Cell Biol. 2011 May 30;193(5):867-84. doi: 10.1083/jcb.201010051.
7
SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
Cell Death Differ. 2011 Jun;18(6):1005-15. doi: 10.1038/cdd.2010.168. Epub 2010 Dec 24.
9
PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.
Blood. 2010 Sep 16;116(11):1971-9. doi: 10.1182/blood-2010-02-269134. Epub 2010 Jun 10.
10
SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
Biochem J. 2010 May 13;428(2):247-54. doi: 10.1042/BJ20091948.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验